QRDA

What’s the Quality Reporting Document Architecture (QRDA)?

The Health Level Seven International (HL7) Quality Reporting Document Architecture (QRDA) is a standard document format for the exchange of electronic clinical quality measure (eCQM) data. QRDA reports:

  • Contain data extracted from electronic health records (EHRs) and other health information technology systems.
  • Can be used to exchange eCQM data between systems.
  • Are the data submission standards for a variety of quality measurement and reporting initiatives.
  • Were adopted by the Office of the National Coordinator for Health Information Technology (ONC) as the standard to support both QRDA Category I (individual patient) and QRDA Category III (provider’s aggregate) data submission approaches for Stage 2 of Meaningful Use (MU2).

QRDA Category I and III specifications have and will be used as Draft Standards for Trial Use (DSTUs). HL7 issues DTSUs during the standards development life cycle when many, but not all, of the guiding requirements have been clarified. DSTUs are tested and then formalized in the HL7 ballot process into an American National Standards Institute (ANSI)-accredited normative standard. QRDA Category I and QRDA Category III DSTUs were published in 2015.

CMS has developed and published a combined CMS QRDA Category I and III Implementation Guide for Eligible Professionals and Eligible Hospitals for the 2016 eCQM reporting. This guide:

  • Is based on the HL7 QRDA Category I, DSTU Release 3, and QRDA Category III, DSTU Release 1, and its July 2014 errata update.
  • Provides CMS-specific requirements for the Eligible Professionals and Eligible Hospitals, such as requiring the CMS Certification Number for hospitals when submitting QRDA Category I reports, by further constraining the base HL7 standard.
  • Further constrains the base HL7 QRDA Category III standard to define CMS specific requirements for aggregated reporting by Eligible Professionals.

QRDA Reference and Implementation Guides for eCQM

For eReporting for the 2017 Reporting Period:

For eReporting for the 2016 Reporting Period:

For eReporting for the 2015 Reporting Period:

For eReporting for the 2014 Reporting Period:

Additional Resources

 

Recent Activity

Thursday, February 16

Friday, January 13

Thursday, January 12

Monday, January 9

Friday, November 11 2016

Friday, September 16 2016

Tuesday, September 13 2016

  • Your profile picture
    5:05pm EDT
    Changes to Body
    -
    *Additional QRDA Guidance*
      
    -
      
     
    *How does the PQRS system determine in a QRDA-I file if a patient is a Medicare patient and therefore HIC number is required?*
     
    *How does the PQRS system determine in a QRDA-I file if a patient is a Medicare patient and therefore HIC number is required?*
      +
     
    All Medicare beneficiaries are assigned a HIC number.  The PQRS system determines whether a patient is a Medicare patient based on the Source of Payment Typology (SOP) code submitted in the Patient Characteristic Payer template. If any of the Patient Characteristic Payer templates includes any of the SOP code listed below, then the HIC number is required for this patient in a QRDA-I file submission to the PQRS system.
     
    All Medicare beneficiaries are assigned a HIC number.  The PQRS system determines whether a patient is a Medicare patient based on the Source of Payment Typology (SOP) code submitted in the Patient Characteristic Payer template. If any of the Patient Characteristic Payer templates includes any of the SOP code listed below, then the HIC number is required for this patient in a QRDA-I file submission to the PQRS system.
     
    1 MEDICARE 
     
    1 MEDICARE 
    Read more
  • Your profile picture
    5:03pm EDT

    How should single administrations be sent to satisfy CONF:1098-7508 for 2016 Reporting Period submissions?

    Issue: Table 132 for Medication Activity (V2) in the HL7 QRDA Category I Release 1 DSTU Release 3 (June 2015) defines the effectiveTime element (i.e. CONF:1098-7508) as being of data type IVL_TS. As such, a substanceAdministration/effectiveTime/@value is not allowed and the CMS receiving system will reject any QRDA-I submission with such a construct in it for the Medication Activity (V2) template.

    Solution: The Medication Activity (V2) conformance statements and the note providing guidance on how to enter this effectiveTime specifically state that the correct way to specify a single administration of a medication is by entering a single time in substanceAdministration/effectiveTime/@value, however, due to the restrictions enforced on IVL_TS data types, for the 2016 reporting period submissions, the proper way to enter a single administration medication is to put the exact same time value that would have gone into substanceAdministration/effectiveTime/@value into both substanceAdministration/effectiveTime/low/@value and substanceAdministration/effectiveTime/high/@value.

    QRDA ONC JIRA Ticket: QRDA-359

    What are all of the reporting strata for CMS137v4 and CMS155v4?

    Please note that the following reporting strata are absent from Table 47 in the 2016 CMS QRDA Implementation Guide Appendix for

    CMS137v4:

    Reporting Stratum 2-1

    66851EB6-67E7-4637-9FD9-A52E2E170D81

    Reporting Stratum 2-2

    6C8BBC46-66CD-4226-B6B5-C8B99C83FD67

    CMS155V4:

    Reporting Stratum 2-1

    F44040FD-D0B5-4C2B-B43D-0A0C47EDFD69

    Reporting Stratum 2-2

    84D8BCA0-4305-47C4-A14F-3F2A751EE58A

    Reporting Stratum 3-1

    415B453B-3FB6-48D5-9661-3AD08A26D979

    Reporting Stratum 3-2

    7C769B9B-7FA0-47E8-B9B0-AB39AF850A11

    The table below lists the Version Specific Measure Identifier, the population identifiers, and the identifiers for reporting strata for CMS137v4 and CMS155v4.

    ...

    Read more